Global Diagnostic Radiopharmaceuticals Market Research Report 2026(Status and Outlook)
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
The global Diagnostic Radiopharmaceuticals market size was estimated at USD 5400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Diagnostic Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Diagnostic Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Diagnostic Radiopharmaceuticals market.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Radiopharmaceuticals Market
Overview of the regional outlook of the Diagnostic Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Diagnostic Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Diagnostic Radiopharmaceuticals market size was estimated at USD 5400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Diagnostic Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Diagnostic Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Diagnostic Radiopharmaceuticals market.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Radiopharmaceuticals Market
Overview of the regional outlook of the Diagnostic Radiopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Diagnostic Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Diagnostic Radiopharmaceuticals Product Life Cycle
3.3 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIAGNOSTIC RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Diagnostic Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Diagnostic Radiopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Diagnostic Radiopharmaceuticals Price by Type (2020-2025)
7 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region
8.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.2.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
8.3.2 North America Diagnostic Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
8.4.2 Europe Diagnostic Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Diagnostic Radiopharmaceuticals Sales by Country
8.6.2 South America Diagnostic Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Diagnostic Radiopharmaceuticals by Region(2020-2025)
9.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Diagnostic Radiopharmaceuticals Production
9.4.1 North America Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Diagnostic Radiopharmaceuticals Production
9.5.1 Europe Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Diagnostic Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Diagnostic Radiopharmaceuticals Production (2020-2025)
9.7.1 China Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Diagnostic Radiopharmaceuticals Product Overview
10.4.3 Novartis Diagnostic Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Diagnostic Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Diagnostic Radiopharmaceuticals Product Overview
10.7.3 Lantheus Diagnostic Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
10.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 China Isotope and Radiation
10.10.1 China Isotope and Radiation Basic Information
10.10.2 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
10.10.3 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Market Performance
10.10.4 China Isotope and Radiation Business Overview
10.10.5 China Isotope and Radiation Recent Developments
10.11 Dongcheng
10.11.1 Dongcheng Basic Information
10.11.2 Dongcheng Diagnostic Radiopharmaceuticals Product Overview
10.11.3 Dongcheng Diagnostic Radiopharmaceuticals Product Market Performance
10.11.4 Dongcheng Business Overview
10.11.5 Dongcheng Recent Developments
11 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast
11.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Diagnostic Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Diagnostic Radiopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2026-2035)
12.1.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals by Type (2026-2035)
12.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Diagnostic Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Diagnostic Radiopharmaceuticals Segment by Type
1.2.2 Diagnostic Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Diagnostic Radiopharmaceuticals Product Life Cycle
3.3 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DIAGNOSTIC RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DIAGNOSTIC RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Diagnostic Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Diagnostic Radiopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Diagnostic Radiopharmaceuticals Price by Type (2020-2025)
7 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Diagnostic Radiopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
8.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region
8.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.2.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
8.3.2 North America Diagnostic Radiopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
8.4.2 Europe Diagnostic Radiopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
8.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Diagnostic Radiopharmaceuticals Sales by Country
8.6.2 South America Diagnostic Radiopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Diagnostic Radiopharmaceuticals by Region(2020-2025)
9.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Diagnostic Radiopharmaceuticals Production
9.4.1 North America Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Diagnostic Radiopharmaceuticals Production
9.5.1 Europe Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Diagnostic Radiopharmaceuticals Production (2020-2025)
9.6.1 Japan Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Diagnostic Radiopharmaceuticals Production (2020-2025)
9.7.1 China Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
10.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
10.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
10.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Diagnostic Radiopharmaceuticals Product Overview
10.4.3 Novartis Diagnostic Radiopharmaceuticals Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
10.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Overview
10.6.3 SIEMENS Diagnostic Radiopharmaceuticals Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Diagnostic Radiopharmaceuticals Product Overview
10.7.3 Lantheus Diagnostic Radiopharmaceuticals Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
10.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
10.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 China Isotope and Radiation
10.10.1 China Isotope and Radiation Basic Information
10.10.2 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
10.10.3 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Market Performance
10.10.4 China Isotope and Radiation Business Overview
10.10.5 China Isotope and Radiation Recent Developments
10.11 Dongcheng
10.11.1 Dongcheng Basic Information
10.11.2 Dongcheng Diagnostic Radiopharmaceuticals Product Overview
10.11.3 Dongcheng Diagnostic Radiopharmaceuticals Product Market Performance
10.11.4 Dongcheng Business Overview
10.11.5 Dongcheng Recent Developments
11 DIAGNOSTIC RADIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast
11.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region
11.2.4 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Diagnostic Radiopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Diagnostic Radiopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2026-2035)
12.1.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals by Type (2026-2035)
12.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Diagnostic Radiopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 5. Diagnostic Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2025)
Table 11. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Type (K MT)
Table 27. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 28. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Diagnostic Radiopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Application
Table 34. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 35. Global Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Diagnostic Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Diagnostic Radiopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Diagnostic Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
Table 64. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
Table 70. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 76. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Diagnostic Radiopharmaceuticals Product Overview
Table 82. Novartis Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 87. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Diagnostic Radiopharmaceuticals Product Overview
Table 92. SIEMENS Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Diagnostic Radiopharmaceuticals Product Overview
Table 97. Lantheus Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
Table 102. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
Table 107. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. China Isotope and Radiation Basic Information
Table 111. China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
Table 112. China Isotope and Radiation Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. China Isotope and Radiation Business Overview
Table 114. China Isotope and Radiation Recent Developments
Table 115. Dongcheng Basic Information
Table 116. Dongcheng Diagnostic Radiopharmaceuticals Product Overview
Table 117. Dongcheng Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Dongcheng Business Overview
Table 119. Dongcheng Recent Developments
Table 120. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Diagnostic Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 5. Diagnostic Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Diagnostic Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals as of 2025)
Table 11. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Diagnostic Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Diagnostic Radiopharmaceuticals Sales by Type (K MT)
Table 27. Global Diagnostic Radiopharmaceuticals Market Size by Type (M USD)
Table 28. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Diagnostic Radiopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Diagnostic Radiopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Diagnostic Radiopharmaceuticals Sales (K MT) by Application
Table 34. Global Diagnostic Radiopharmaceuticals Market Size by Application
Table 35. Global Diagnostic Radiopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Diagnostic Radiopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Diagnostic Radiopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Diagnostic Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Diagnostic Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Diagnostic Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Diagnostic Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Diagnostic Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
Table 64. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
Table 70. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 76. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Diagnostic Radiopharmaceuticals Product Overview
Table 82. Novartis Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
Table 87. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Diagnostic Radiopharmaceuticals Product Overview
Table 92. SIEMENS Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Diagnostic Radiopharmaceuticals Product Overview
Table 97. Lantheus Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
Table 102. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
Table 107. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. China Isotope and Radiation Basic Information
Table 111. China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
Table 112. China Isotope and Radiation Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. China Isotope and Radiation Business Overview
Table 114. China Isotope and Radiation Recent Developments
Table 115. Dongcheng Basic Information
Table 116. Dongcheng Diagnostic Radiopharmaceuticals Product Overview
Table 117. Dongcheng Diagnostic Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Dongcheng Business Overview
Table 119. Dongcheng Recent Developments
Table 120. Global Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 121. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 123. North America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 125. Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Diagnostic Radiopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 127. Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 129. South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Diagnostic Radiopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 133. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Diagnostic Radiopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 135. Global Diagnostic Radiopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 136. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Radiopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Diagnostic Radiopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Diagnostic Radiopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Diagnostic Radiopharmaceuticals Product Life Cycle
Figure 13. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Diagnostic Radiopharmaceuticals
Figure 19. Global Diagnostic Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Diagnostic Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2025
Figure 29. Market Share of Diagnostic Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Diagnostic Radiopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Diagnostic Radiopharmaceuticals Market Share by Application
Figure 33. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Diagnostic Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2025
Figure 37. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Diagnostic Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Diagnostic Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Diagnostic Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Diagnostic Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region in 2024
Figure 68. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Diagnostic Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Diagnostic Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Diagnostic Radiopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Radiopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Diagnostic Radiopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Diagnostic Radiopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Diagnostic Radiopharmaceuticals Product Life Cycle
Figure 13. Diagnostic Radiopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Diagnostic Radiopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Diagnostic Radiopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Diagnostic Radiopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Diagnostic Radiopharmaceuticals
Figure 19. Global Diagnostic Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Diagnostic Radiopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Diagnostic Radiopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Diagnostic Radiopharmaceuticals by Type in 2025
Figure 29. Market Share of Diagnostic Radiopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Diagnostic Radiopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Diagnostic Radiopharmaceuticals Market Share by Application
Figure 33. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Diagnostic Radiopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Diagnostic Radiopharmaceuticals Market Share by Application in 2025
Figure 37. Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Diagnostic Radiopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Diagnostic Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Diagnostic Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Diagnostic Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Diagnostic Radiopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region in 2024
Figure 68. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Diagnostic Radiopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Diagnostic Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Diagnostic Radiopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Diagnostic Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Diagnostic Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Diagnostic Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Diagnostic Radiopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Diagnostic Radiopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Diagnostic Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Diagnostic Radiopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Diagnostic Radiopharmaceuticals Market Share Forecast by Application (2026-2035)
